These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1718088

  • 1. Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.
    Callebaut I, Burny A, Krchnák V, Gras-Masse H, Wathelet B, Portetelle D.
    Virology; 1991 Nov; 185(1):48-55. PubMed ID: 1718088
    [Abstract] [Full Text] [Related]

  • 2. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
    Portetelle D, Dandoy C, Burny A, Zavada J, Siakkou H, Gras-Masse H, Drobecq H, Tartar A.
    Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
    [Abstract] [Full Text] [Related]

  • 3. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
    Ban J, Czene S, Altaner C, Callebaut I, Krchnak V, Merza M, Burny A, Kettmann R, Portetelle D.
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
    [Abstract] [Full Text] [Related]

  • 4. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.
    Callebaut I, Vonèche V, Mager A, Fumière O, Krchnak V, Merza M, Zavada J, Mammerickx M, Burny A, Portetelle D.
    J Virol; 1993 Sep; 67(9):5321-7. PubMed ID: 7688821
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
    Bai L, Otsuki H, Sato H, Kohara J, Isogai E, Takeshima SN, Aida Y.
    Retrovirology; 2015 Dec 30; 12():106. PubMed ID: 26715158
    [Abstract] [Full Text] [Related]

  • 6. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep.
    Bruck C, Portetelle D, Mammerickx M, Mathot S, Burny A.
    Leuk Res; 1984 Dec 30; 8(3):315-21. PubMed ID: 6205222
    [Abstract] [Full Text] [Related]

  • 7. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
    Portetelle D, Couez D, Bruck C, Kettmann R, Mammerickx M, Van der Maaten M, Brasseur R, Burny A.
    Virology; 1989 Mar 30; 169(1):27-33. PubMed ID: 2466370
    [Abstract] [Full Text] [Related]

  • 8. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
    De Giuseppe A, Feliziani F, Rutili D, De Mia GM.
    Clin Diagn Lab Immunol; 2004 Jan 30; 11(1):147-51. PubMed ID: 14715562
    [Abstract] [Full Text] [Related]

  • 9. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
    Legrain M, Portetelle D, Dumont J, Burny A, Hilger F.
    Gene; 1989 Jul 15; 79(2):227-37. PubMed ID: 2551774
    [Abstract] [Full Text] [Related]

  • 10. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data.
    Callebaut I, Mornon JP, Burny A, Portetelle D.
    Leukemia; 1994 Apr 15; 8 Suppl 1():S218-21. PubMed ID: 7512181
    [Abstract] [Full Text] [Related]

  • 11. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
    Gatei MH, Naif HM, Kumar S, Boyle DB, Daniel RC, Good MF, Lavin MF.
    J Virol; 1993 Apr 15; 67(4):1803-10. PubMed ID: 7680387
    [Abstract] [Full Text] [Related]

  • 12. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
    Portetelle D, Burny A, Desmettre P, Mammerickx M, Paoletti E, Zavada J.
    Dev Biol Stand; 1990 Apr 15; 72():81-90. PubMed ID: 1704325
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.
    Portetelle D, Mammerickx M, Burny A.
    J Virol Methods; 1989 Feb 15; 23(2):211-22. PubMed ID: 2542354
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.
    Orlik O, Ban J, Hlavaty J, Altaner C, Kettmann R, Portetelle D, Splitter GA.
    J Virol; 1997 Apr 15; 71(4):3263-7. PubMed ID: 9060692
    [Abstract] [Full Text] [Related]

  • 20. Bovine leukaemia virus ISCOMs: biochemical characterization.
    Merza MS, Linné T, Höglund S, Portetelle D, Burny A, Morein B.
    Vaccine; 1989 Feb 15; 7(1):22-8. PubMed ID: 2541575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.